Genomewide association analysis on green tea chemoprevention of colorectal adenoma: the importance of SLCO1A2 variants.
- 2025-04-01
- RCT · n = 550
- Pharmacogenomics 26(5-6)
- J Stingl
- C Scholl
- M Steffens
- P Koczera
- R Muche
- F Rohlmann
- Th Ettrich
- Th Seufferlein
- PubMed: 40433816
- DOI: 10.1080/14622416.2025.2510186
- High evidence
- Large Human Trial
In the variant carriers, the adenoma frequency was 41.4% in the green tea group and 35.7% in the placebo group (RR 1.16 [0.81; 1.65] p = 0.61)
- Effect
- Neutral
- Effect size
- Small
- Significant
- No